scholarly journals The influence of breast cancer subtype on survival after palliative radiation for osseous metastases

2020 ◽  
Vol 9 (23) ◽  
pp. 8979-8988
Author(s):  
Mohamed K. Abdelhakiem ◽  
Candice Johnstone ◽  
Carmen Bergom ◽  
Adam Currey ◽  
Jared R. Robbins
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Subtype ◽  
Palliative Radiation ◽  
Osseous Metastases ◽  
Cancer Subtype

The Influence of Breast Cancer Subtype on Survival after Palliative Radiation for Osseous Metastases

2018 ◽  
Vol 102 (3) ◽  
pp. e436
Author(s):  
M.K. Abdelhakiem ◽  
C. Johnstone ◽  
C. Bergom ◽  
A.D. Currey ◽  
J.R. Robbins
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Subtype ◽  
Palliative Radiation ◽  
Osseous Metastases ◽  
Cancer Subtype

scholarly journals Are the estrogen receptor and SIRT3 axes of the mitochondrial UPR key regulators of breast cancer subtype determination according to age?

2021 ◽  
Author(s):  
Edmund Charles Jenkins ◽  
Mrittika Chattopadhyay ◽  
Doris Germain
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Breast Cancer Subtype ◽  
Cancer Subtype

scholarly journals Erratum to: Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women

2017 ◽  
Vol 166 (1) ◽  
pp. 195-195 ◽  
Author(s):  
María Elena Martínez ◽  
Scarlett L. Gomez ◽  
Li Tao ◽  
Rosemary Cress ◽  
Danielle Rodriguez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Socioeconomic Factors ◽  
White Women ◽  
Breast Cancer Subtype ◽  
Cancer Subtype ◽  
Hispanic White

scholarly journals Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer

2010 ◽  
Vol 1 (5) ◽  
pp. 747-754 ◽  
Author(s):  
REIKI NISHIMURA ◽  
TOMOFUMI OSAKO ◽  
YASUHIRO OKUMURA ◽  
MITSUHIRO HAYASHI ◽  
YASUO TOYOZUMI ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Marker ◽  
Primary Breast Cancer ◽  
Breast Cancer Subtype ◽  
Recurrence Time ◽  
Ki 67 ◽  
Cancer Subtype

Immunohistochemical Profiles of Breast Cancer Patients at MRCCC Siloam Semanggi Hospital in 2018

2021 ◽  
Vol 11 (5) ◽  
pp. 392-400
Author(s):  
Fajar Lamhot Gultom ◽  
Marliana Nurprilinda ◽  
Ryani Nur Cahyaning Hutami
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Subtype ◽  
Breast Cancer Patients ◽  
Ki 67 ◽  
Proliferation Markers ◽  
Luminal B ◽  
Cancer Subtype ◽  
Anatomy Laboratory ◽  
Grade Ii ◽  
Her 2

Immunohistochemistry examination (IHC) is one of the additional tests to diagnose and determine breast cancer subtype. IHC examination is a method to check intracellular protein using a monoclonal and polyclonal antibody to detect the antigen in tissue. IHC examination determined by hormone receptor markers (ER and PR), HER-2/Neu expression, and apoptotic and proliferation markers (Ki-67 and p53) can be used to determine therapy and prognosis. This study aims to determine the hormonal status of breast cancer patient at Siloam Semanggi Hospital in 2018, in the form of age, gender, pathology diagnose, and the result of IHC (ER, PR, HER2, and Ki-67). This study is a retrospective descriptive study using pathological anatomy laboratory results of breast cancer in MRCCC Siloam Semanggi Hospital and 208 patients following inclusion and exclusion criteria. The result obtained is that the age group with the highest frequency is 50-59 years, with 34.1%. The highest frequency by gender is a woman with 99.5%. Carcinoma mammae NST with grade II and III was found in 38.0% of patients. The hormonal receptor with ER and PR positive was found in 51.0% of patients. HER2 expression negative was found in 56.7% of patients. High proliferation Ki-67 was found in 82.7% of patients. Luminal B with HER2 negative subtype was found in 32.2% of patients. Patients in 50-59 years with Luminal B with HER2 negative subtype was found in 26 patients. Patients in carcinoma mammae NST with grade II with Luminal B with HER2 negative subtype was found in 27 patients. Keywords: Breast cancer, pathologic anatomy, immunohistochemistry, breast cancer subtype

scholarly journals Expression of long non‐coding RNA ENSG 00000226738 (Lnc KLHDC 7B) is enriched in the immunomodulatory triple‐negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death

2019 ◽  
Vol 13 (4) ◽  
pp. 909-927 ◽  
Author(s):  
Fredy Omar Beltrán‐Anaya ◽  
Sandra Romero‐Córdoba ◽  
Rosa Rebollar‐Vega ◽  
Oscar Arrieta ◽  
Verónica Bautista‐Piña ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Cell Migration ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Subtype ◽  
Non Coding Rna ◽  
Cancer Subtype ◽  
Long Non Coding Rna

scholarly journals Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0234191 ◽  
Author(s):  
Anne-Sophie Hamy ◽  
Lauren Darrigues ◽  
Enora Laas ◽  
Diane De Croze ◽  
Lucian Topciu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Prognostic Value ◽  
Breast Cancer Subtype ◽  
Residual Cancer ◽  
Cancer Burden ◽  
Residual Cancer Burden ◽  
Cancer Subtype

scholarly journals Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1

2020 ◽  
Vol 11 (8) ◽  
Author(s):  
Minmin Fan ◽  
Jingwei Chen ◽  
Jian Gao ◽  
Wenwen Xue ◽  
Yixuan Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Small Molecule ◽  
Breast Cancer Subtype ◽  
Cancer Subtype
Sign in / Sign up

Export Citation Format

Share Document